[HTML][HTML] Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis

RR Ling, K Ramanathan, FL Tan, BC Tai… - The Lancet …, 2022 - thelancet.com
Background Myopericarditis is a rare complication of vaccination. However, there have been
increasing reports of myopericarditis following COVID-19 vaccination, especially among …

US Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines

D Gubernot, A Jazwa, M Niu, J Baumblatt, J Gee… - Vaccine, 2021 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has had a devastating
impact on global health, and has resulted in an unprecedented, international collaborative …

[HTML][HTML] Clinical presentation and outcomes of acute pericarditis in a large urban hospital in the United States of America

A Vecchié, JG Chiabrando, MS Dell, A Bonaventura… - Chest, 2020 - Elsevier
Background Acute pericarditis is the most common presentation of pericardial diseases.
Although generally benign, complications such as constrictive pericarditis, cardiac …

Pericardial disease in the developing world

M Ntsekhe - Canadian Journal of Cardiology, 2023 - Elsevier
Pericardial disease in the developing world is dominated primarily by effusive and
constrictive syndromes and contributes to the acute and chronic heart failure burden in many …

Advances in imaging and targeted therapies for recurrent pericarditis: a review

S Kumar, S Khubber, R Reyaldeen, A Agrawal… - JAMA …, 2022 - jamanetwork.com
Importance Pericarditis is the most common form of pericardial disease. Recurrence of
pericarditis affects 15% to 30% of patients after the initial episode of pericarditis. Up to 50 …

Trends in acute pericarditis hospitalizations and outcomes among the elderly in the USA, 1999–2012

P Mody, B Bikdeli, Y Wang, M Imazio… - … Heart Journal-Quality …, 2018 - academic.oup.com
Aims The elderly are at risk of pericarditis from conditions such as malignancy, renal
disease, and after cardiac surgery. However, the burden of pericarditis and, especially, the …

JYNNEOS vaccine safety surveillance during the 2022 mpox outbreak using the Vaccine Adverse Event Reporting System (VAERS) and v-safe, United States, 2022 …

J Duffy, TR Myers, P Marquez, D Rouse… - Sexually Transmitted …, 2024 - journals.lww.com
Background In response to the 2022 mpox outbreak in the United States, people with higher
potential for exposure to mpox were recommended to receive two doses of the JYNNEOS …

Disease and economic burden associated with recurrent pericarditis in a privately insured United States population

D Lin, F Laliberté, C Majeski, M Magestro, D Lejeune… - Advances in …, 2021 - Springer
Introduction Approximately 30% of patients with a first acute pericarditis episode experience
a recurrence≤ 18 months;~ 15% experience multiple recurrences. This study assessed the …

Diversity in acute autoimmune pericarditis: nationwide analysis of in-hospital outcomes and recurrence

H Aikawa, M Fujino, K Nakao, M Nakai, K Kanaoka… - JACC: Asia, 2024 - jacc.org
Background Acute autoimmune pericarditis (AAP) is an uncommon disease with diverse
etiology. Data regarding AAP diagnosis and outcomes are scant. Objectives This study …

Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273

V Urdaneta, DB Esposito, P Dharia… - Open Forum …, 2024 - academic.oup.com
Background Large-scale use of mRNA COVID-19 vaccines during the pandemic was
associated with enhanced safety monitoring to ensure accurate and timely review of safety …